Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Genitourinary 1

Conditions

Renal Insufficiency, Chronic 1Polycystic Kidney, Autosomal Dominant 1Hypertension 1Hepatitis B 1Hematologic Neoplasms 1Chronic Kidney Disease-Mineral and Bone Disorder 1Carcinoma, Hepatocellular 1

Interventions

Cyclophosphamide 87fludarabine 77fludarabine phosphate 45Tacrolimus 45Whole-Body Irradiation 42Mycophenolic Acid 42Busulfan 35Melphalan 32Antilymphocyte Serum 24Methotrexate 23thymoglobulin 22Standard of Care 22Rituximab 22Thiotepa 20Sirolimus 20Azacitidine 20venetoclax 19Stem Cell Transplantation 18Granulocyte Colony-Stimulating Factor 18Practice Guidelines as Topic 17Cytarabine 16Bortezomib 16Nivolumab 15Filgrastim 15Specimen Handling 14Dexamethasone 14Blood Specimen Collection 14Cyclosporine 13Surveys and Questionnaires 12Mesna 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hematologic Neoplasms × Polymorphism, Genetic × Clear all
NCT06416761 2024-05-16

Genetics in the Progression of Nephropathies

Ospedale San Raffaele

Recruiting
10,000 enrolled
GenitourinaryOther hematologic neoplasm

Hypertension, Chronic Kidney Disease-Mineral and Bone Disorder, Polycystic Kidney, Autosomal Dominant, Hematologic Neoplasms, Renal Insufficiency, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡